Literature DB >> 3501857

Treatment of acute exacerbations of chronic bronchitis with ciprofloxacin.

J A Hoogkamp-Korstanje1, S J Klein.   

Abstract

Thirty four patients with acute purulent exacerbations of chronic bronchitis were treated with 500 mg ciprofloxacin twice daily, orally, for ten days. Short time cure rate was 97% (cure 71%, improvement 26%) and failure 3%, long time cure rate (six months follow-up) was 74%. Predominant initial pathogens were Haemophilus influenzae and Streptococcus pneumoniae, mostly in pure cultures. All sputum cultures except those with Streptococcus pneumoniae became negative on the third day of treatment. Apart from a slower clearance of pneumococci from sputum there were no significant differences in responses between pneumococcal and Haemophilus infections during and after therapy. Mild adverse gastrointestinal effects were noticed in five patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501857     DOI: 10.1007/BF02075263

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  5 in total

1.  Clinical efficacy of ciprofloxacin in the treatment of patients with respiratory tract infections in Japan.

Authors:  H Kobayashi
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

Review 2.  Drug interactions of ciprofloxacin with other non-antibiotic agents.

Authors:  E Rubinstein; S Segev
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

3.  Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapy.

Authors:  J A Hoogkamp-Korstanje
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

4.  Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin.

Authors:  I C Gleadhill; W P Ferguson; R C Lowry
Journal:  J Antimicrob Chemother       Date:  1986-11       Impact factor: 5.790

5.  Ciprofloxacin in acute exacerbations of chronic bronchitis.

Authors:  J A Hoogkamp-Korstanje; S J Klein
Journal:  J Antimicrob Chemother       Date:  1986-09       Impact factor: 5.790

  5 in total
  1 in total

1.  Two different dosages of ciprofloxacin in patients with respiratory tract infections.

Authors:  T Brutel de la Rivière; M S Daniëls-Bosman; G P ten Velde
Journal:  Pharm Weekbl Sci       Date:  1989-08-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.